Authors:
CATALONA WJ
PARTIN AW
SLAWIN KM
BRAWER MK
FLANIGAN RC
PATEL A
RICHIE JP
DEKERNION JB
WALSH PC
SCARDINO PT
LANGE PH
SUBONG ENP
PARSON RE
GASIOR GH
LOVELAND KG
SOUTHWICK PC
Citation: Wj. Catalona et al., USE OF THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN TO ENHANCE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - A PROSPECTIVE MULTICENTER CLINICAL-TRIAL, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1542-1547
Authors:
LOVELAND KG
SOUTHWICK PC
DAGOSTINO D
RATLIFF TL
BECK J
LAMB DJ
LOTT N
DAUM P
WENER MH
KELLEY CA
CHAN DW
KASKE D
GOLIGHTLY D
LAYCO G
OTA M
MCBRIDE JH
GRUDZIEN C
TANASIJEVIC MJ
GASIOR GH
Citation: Kg. Loveland et al., ANALYSIS OF HYBRITECH TANDEM(R) FREE PSA IN THE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - RESULTS OF A MULTICENTERCLINICAL-TRIAL, Clinical chemistry, 43, 1997, pp. 553-553
Authors:
PARTIN AW
CATALONA WJ
SOUTHWICK PC
SUBONG ENP
GASIOR GH
CHAN DW
Citation: Aw. Partin et al., ANALYSIS OF PERCENT FREE PROSTATE-SPECIFIC ANTIGEN (PSA) FOR PROSTATE-CANCER DETECTION - INFLUENCE OF TOTAL PSA, PROSTATE VOLUME, AND AGE, Urology, 48(6A), 1996, pp. 55-61
Authors:
SOUTHWICK PC
CATALONA WJ
PARTIN AW
RATLIFF TL
CHAN DW
WALSH PC
SUBONG ENP
KELLEY CA
GASIOR GH
Citation: Pc. Southwick et al., USE OF THE TANDEM(R) PSA RATIO (FREE TOTAL PSA) IN DISTINGUISHING BETWEEN PROSTATE-CANCER (PCA) AND BENIGN PROSTATIC HYPERPLASIA (BPH)/, Clinical chemistry, 42(6), 1996, pp. 667-667